COAGNasdaq

Hemab Therapeutics Holdings, Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 2114044

Develops and commercializes therapies for blood coagulation disorders, focusing on prophylactic treatments

red 8-K · 90d

$1.17B

Market cap

$36.73

Last close

+13.5%

+15.7%

362K

Volume

Price · last 39 sessions+44.9%

May 4L $24.98 · H $36.73Jun 29

Total filings

May 21, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance